Medical Microbiology Testing Technologies Market to be Worth US$3.4 Bn by 2024: Demand for Automation in Microbiology Research Assures Growth, Notes TMR

Wednesday, February 15, 2017 Research News
Email Print This Page Comment

ALBANY, New York, February 15, 2017 /PRNewswire/ --

Transparency Market Research points out that the leading players

operating in the Global Medical Microbiology Testing Technologies Market Abbott Laboratories, Agilent Technologies, Becton, Dickinson and Company, and Beckman Coulter, Inc. These players are focused on new product
development, diversification, market development, penetration to retain their dominance over the forecast period.

According to the research report, the global medical microbiology testing technologies market is expected to be worth US$3.4 bn by the end of 2024 from US$2.1 bn in 2015. During the forecast years of 2016 and 2024, the global market is expected to expand at a CAGR of 5.4% due to the increasing demand for automation in the field of medical microbiology.

Europe to Lead the Pack as Uptake of Technology Improves 

Geographically, this global medical microbiology testing technologies market is segmented into North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. The report suggests that Europe and North America will offer the global market lucrative opportunities in the near future. Europe is estimated to dominate the global market as the regional market expands at a CAGR of 4.8% between 2016 and 2024. The growing demand for improved microbiology technologies in the region is expected to boost the demand in the coming years.

Download PDF Brochure of Research Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11603

On the basis of indication, the global market for medical microbiology testing technologies is categorized into respiratory diseases, neurological diseases, infectious diseases, and others. Of all these segments, the infectious diseases segment is expected to acquire a share of 41% in the global market by the end of 2024 in terms of volume. The high incidence of infectious diseases across the globe is expected to drive this segment in the near future.

Increasing Government Investments Boost Global Market 

The growing government investments in the research of life sciences and biological and medical sciences are largely responsible for the accelerated pace of growth of the overall market. The report predicts that government investments are likely to continue in the coming years as this research is characterized by high risk and long duration, which makes it unattractive for companies looking to make quick profits. The market is also expected to be driven by the high prevalence of infectious diseases and emerging infectious diseases, especially among the population of the developing nations. The commonly seen infectious diseases affecting individuals across the globe are impetigo, urinary tract infections, and pneumonia. Furthermore, the growing demand for automation in medical microbiology for specimen management, nucleic acid amplification, identification, microbial detection, and susceptibility testing is also estimated to benefit the global market.

High Costs and Complex Procedures Restrain Global Market 

The global medical microbiology testing technologies market is being restrained by the high cost associated with various types of media. Analysts anticipate that the global market will also be held back due to the complexities involved in sample preparation techniques. The premium pricing of using medical microbiology technologies are also projected to limit the growth of the global market through the forecast period. Lastly, the impact of point-of-care testing is also proving to be a negative one on the overall market.

Inquire for Report Customization:  

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11603

This review is based on Transparency Market Research's review, titled "Medical Microbiology Testing Technologies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016 - 2024."

The market has been segmented as below: 

Global Medical Microbiology Testing Technologies Market - By Indication 

  • Respiratory Diseases
  • Neurological Diseases
  • Infectious Diseases
  • Others

Global Medical Microbiology Testing Technologies Market - By Technology 

  • Cell Culture
  • Microscopy
  • Serology

Global Medical Microbiology Testing Technologies Market - By Application 

  • Diagnostic
  • Treatment Monitoring

Global Medical Microbiology Testing Technologies Market - By End User 

  • Hospital Labs
  • Pathology Labs
  • Research Institutes
  • Others

Global Medical Microbiology Testing Technologies Market - By Region 

  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • Japan
    • Australia
    • New Zealand
    • Rest of Asia Pacific
  • Middle East and Africa (MEA)
    • Saudi Arabia
    • UAE
    • RSA
    • Rest of MEA

Browse Related Research Report: 

Cell Culture Market (Consumables: Media, Sera, Reagents; and Instruments: Culture Systems, Incubators, Bioreactors, Pipetting Instruments, Roller Bottle Equipment, Biosafety Cabinets, Cryostorage Equipment, Others): Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022

http://www.transparencymarketresearch.com/cell-culture-market.html

Neurological Disorder Drugs Market (Disorder - Epilepsy, Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, and Cerebrovascular Disease; Drug Type - Anticholinergic, Antiepileptic, Antipsychotic, Analgesics, Hypnotic & Sedative, Antihypertensive, and Anticoagulants; Distribution Channel - Hospital Pharmacy, Retail Pharmacy, and eCommerce) - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

http://www.transparencymarketresearch.com/europe-neurological-disorder-drugs-market.html

Respiratory Disease Testing Market (By Tests - Imaging, Spirometry, Peak Flow, Blood Gas, Lung Volume, and Other Tests); (By End-User - Hospitals, Physician Offices and Clinical Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022

http://www.transparencymarketresearch.com/respiratory-disease-testing.html

About Us: 

Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR's global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact Us: Transparency Market Research 90 State Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

Blog: http://www.tmrblog.com/

SOURCE Transparency Market Research



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.


Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook